Excessive Hypocapnic Cerebral Vasoconstriction in Hypermobile Ehlers–Danlos Syndrome Assessed With Real‐Time Magnetic Resonance Imaging During Lower‐Body Negative Pressure
Darius A Gerlach; Anja Bach; Laura de Boni; Fiona Fischer; Tatjana Barth; Alex Hoff; Jorge Manuel; Jens Jordan; Andrea...
Baroreflex sensitivity impairment in Long-COVID patients: a diagnostic tool for classifying the autonomic dysfunction spectrum
BACKGROUND
Long-COVID describes a variety of COVID-19 side effects lasting longer than three months. Among these side effects are cardiovascular alterations, such as...
Familial Chiari Malformation: Prevalence of Connective Tissue Disorders and Other Comorbidities
Heukwa-Tefoung, Anne; Bui, Alicia; Gilmer, Holly
BACKGROUND AND OBJECTIVES:
Chiari malformation type 1 (CM-I) is frequently associated with connective tissue disorders (CTDs), particularly...
Frequency and characteristics of multi‐domain autonomic dysfunction in patients with spontaneous intracranial hypotension
Abstract
Objective
We aimed to evaluate multi-domain autonomic function in patients with spontaneous intracranial hypotension (SIH) and investigate its association with...
Hello, first post on the forums, and I'm posting on behalf my spouse who is experiencing severe ME.
The specific ME problems are severe PEM, being bed-bound for months now, inability to deal with screens for more than seconds at a time, no ability to read or research, daydreaming can also cause...
Background: Prior to the COVID-19 pandemic, the etiology of postural orthostatic tachycardia syndrome (POTS) remained elusive. Since the pandemic, a newly recognized disorder, termed Long COVID, has emerged with a significant subset of patients developing dysautonomia and a multitude of...
https://cen.acs.org/pharmaceuticals/drug-development/long-covid-pots-mecfs-drug-trials-ethics/104/web/2026/07
4000-word article.
Access to potential long COVID drugs dwindles as trials falter
Two sets of studies for COVID-driven conditions show the struggles of drug development
by Rowan Walrath...
The body and the brain keep the score: a data-driven conceptual model linking trauma and postural tachycardia syndrome
Abstract
Postural tachycardia syndrome (POTS) is a common, often disabling disorder of autonomic nervous system regulation without a unifying etiological account. Converging...
Abstract
Postural orthostatic tachycardia syndrome (POTS) as conventionally defined is a chronic condition (typically > 3 months duration) incorporating reproducible symptoms of orthostatic intolerance (including dizziness/lightheadedness, and near-syncope) in the absence of orthostatic...
An abstarct was presented during the American College of Cardiology's 75th Annual Scientific Session & Expo, 28-30 March 2026
BACKGROUND Patients with postural orthostatic tachycardia syndrome (POTS) exhibit unique hemodynamics. Invasive cardiopulmonary exercise testing (iCPET) may provide...
Hives in autonomic disorders: a cutaneous marker of a distinct symptom phenotype
Abstract
Background
Postural Orthostatic Tachycardia Syndrome (POTS) and Neurally-Mediated Hypotension (NMH) are heterogeneous syndromes characterized by dysautonomia and multisystem symptoms.
Mast cell...
Disequilibrium, Rather than Postural Orthostatic Tachycardia Syndrome, Is the Primary Determinant of Orthostatic Intolerance in Patients with Long COVID
Miwa, Kunihisa
Background
Orthostatic intolerance (OI) is an important factor affecting daily functional capacity in patients with long...
Abstract
Background
Postural orthostatic tachycardia syndrome (POTS) is a chronic autonomic disorder associated with debilitating symptoms. No medications have been approved for treatment, and patients commonly use off-label medications to treat symptoms. The hemodynamic implications of certain...
Postural orthostatic tachycardia is not a useful diagnostic marker for chronic fatigue syndrome
M. E. Roerink, J. W. M. Lenders, I. C. Schmits, A. M. A. Pistorius, J. W. Smit, H. Knoop, J. W. M. van der Meer
First published: 02 October 2016
https://doi.org/10.1111/joim.12564
Abstract...
Shared autonomic phenotype of long COVID and myalgic encephalomyelitis/chronic fatigue syndrome
Peter Novak; David M Systrom; Alexandra Witte; Sadie P Marciano; Donna Felsenstein; Jeff M Milunsky; Aubrey Milunsky; Joel Krier; Mark C Fishman
INTRODUCTION
Long COVID and myalgic...
Impact of COVID‑19 infection on subsequent prescriptions of autonomic dysfunction pharmacotherapy: a nationwide propensity‑score‑matched Cohort study in Japan
Daisuke Miyamori; Masanori Ito
BACKGROUND
Autonomic dysfunction, including orthostatic hypotension and postural tachycardia syndrome...
Key Points
Question What is the prevalence of central sensitization syndrome in postural tachycardia syndrome (POTS)?
Findings This case-control study of 305 patients found a high prevalence (86.5%) of central sensitization syndrome in individuals with POTS.
Meaning These findings suggest...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.